Targeting intracellular signaling: a novel approach to vaccination.
Vaccination is well known to control many current infectious diseases. However, the development of cellular (Th1) immunity to control viral pathogens, among others, requires the development of new vaccine adjuvants. The use of Toll-like receptor ligands or cytokines has shown much promise, although...
Prif Awduron: | Wales, J, Foxwell, B, Feldmann, M |
---|---|
Fformat: | Journal article |
Iaith: | English |
Cyhoeddwyd: |
2007
|
Eitemau Tebyg
-
Targeting intracellular mediators of pattern-recognition receptor signalling to adjuvant vaccination.
gan: Wales, J, et al.
Cyhoeddwyd: (2007) -
Targeting intracellular mediators of pattern-recognition receptor signalling to adjuvant vaccination
gan: Wales, J, et al.
Cyhoeddwyd: (2007) -
Activation of NF-kappaB by the intracellular expression of NF-kappaB-inducing kinase acts as a powerful vaccine adjuvant.
gan: Andreakos, E, et al.
Cyhoeddwyd: (2006) -
Is targeting Toll-like receptors and their signaling pathway a useful therapeutic approach to modulating cytokine-driven inflammation?
gan: Andreakos, E, et al.
Cyhoeddwyd: (2004) -
Imaging of intracellular targets
gan: Kersemans, V
Cyhoeddwyd: (2016)